• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ERJ Open Res . Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality

tetano

Editor, Senior Moderator
ERJ Open Res


. 2023 Apr 11;9(2):00554-2022.
doi: 10.1183/23120541.00554-2022. eCollection 2023 Mar.
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality


Adel Maamar[SUP] 1 2 [/SUP], Pauline Guillot[SUP] 1 2 [/SUP], Vincent Joussellin[SUP] 1 2 [/SUP], Flora Delamaire[SUP] 1 2 [/SUP], Benoit Painvin[SUP] 1 2 [/SUP], Anaëlle Bichon[SUP] 1 2 [/SUP], Océane Bernard de la Jartre[SUP] 1 2 [/SUP], Matteo Mauget[SUP] 1 2 [/SUP], Mathieu Lesouhaitier[SUP] 1 2 3 [/SUP], Jean Marc Tadié[SUP] 1 2 3 [/SUP], Nicolas Terzi[SUP] 1 2 3 [/SUP], Arnaud Gacouin[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Background: This study aimed to compare ventilatory parameters recorded in the first days of acute respiratory distress syndrome (ARDS) and mortality at day 60 between coronavirus disease 2019 (COVID-19) and influenza ARDS patients with arterial oxygen tension (P [SUB]aO[SUB]2[/SUB][/SUB] )/inspiratory oxygen fraction (F [SUB]IO[SUB]2[/SUB][/SUB] ) ≤150 mmHg.
Methods: We compared 244 COVID-19 ARDS patients with 106 influenza ARDS patients. Driving pressure, respiratory system compliance (C [SUB]rs[/SUB]), ventilator ratio, corrected minute ventilation (V'[SUB]Ecorr[/SUB]) and surrogate of mechanical power (index=(4×driving pressure)+respiratory rate) were calculated from day 1 to day 5 of ARDS. A propensity score analysis and a principal component analysis (PCA) were performed.
Results: On day 1 of ARDS, COVID-19 patients had significantly higher P [SUB]aO[SUB]2[/SUB][/SUB] /F [SUB]IO[SUB]2[/SUB][/SUB] (median (interquartile range) 97 (79-129.2) versus 83 (62.2-114) mmHg; p=0.001), and lower driving pressure (13.0 (11.0-16.0) versus 14.0 (12.0-16.7) cmH[SUB]2[/SUB]O; p=0.01), ventilatory ratio (2.08 (1.73-2.49 versus 2.52 (1.97-3.03); p<0.001), V'[SUB]Ecorr[/SUB] (12.7 (10.2-14.9) versus 14.9 (11.6-18.6) L·min[SUP]-1[/SUP]; p<0.001) and index (80 (70-89) versus 84 (75-94); p=0.004). PCA demonstrated an important overlap of ventilatory parameters recorded on day 1 between the two groups. From day 1 to day 5, repeated values of P [SUB]aO[SUB]2[/SUB][/SUB] /F [SUB]IO[SUB]2[/SUB][/SUB] , arterial carbon dioxide tension, ventilatory ratio and V'[SUB]Ecorr[/SUB] differed significantly between influenza and COVID-19 patients in the unmatched and matched populations. Mortality at day 60 did not differ significantly after matching (29% versus 21.7%; p=0.43).
Conclusions: Ventilation was more impaired in influenza than in COVID-19 ARDS patients on the first day of ARDS with an important overlap of values. However, mortality at day 60 did not differ significantly in the matched population.
 
Back
Top Bottom